Yun Zhong
Stock Analyst at Wedbush
(0.08)
# 4,317
Out of 4,361 analysts
399
Total ratings
37.7%
Success rate
-10.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Maintained: Buy | $5 → $6 | $4.00 | +50.00% | 23 | Jun 2, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 | $3.43 | +133.24% | 24 | Jun 1, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $17 | $4.65 | +265.59% | 2 | Jun 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $15 | $5.69 | +163.62% | 20 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $94 | $53.32 | +76.29% | 16 | May 21, 2026 | |
| KROS Keros Therapeutics | Maintained: Hold | $16 | $10.55 | +51.66% | 15 | May 19, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | $8 | $3.59 | +122.84% | 23 | May 18, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Buy | $35 | $16.25 | +115.38% | 29 | May 15, 2026 | |
| SGMT Sagimet Biosciences | Maintained: Buy | $28 | $6.79 | +312.37% | 9 | May 13, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $10 | $3.99 | +150.63% | 6 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $17.87 | +90.26% | 19 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $2.89 | +453.63% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.97 | +101.51% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $273 | $216.60 | +26.04% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $112 → $118 | $93.23 | +26.57% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $5.90 | +35.71% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $2.79 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.69 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $26.76 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $27.43 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $6.41 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.3394 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.13 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $81.57 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.42 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $19.35 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.86 | n/a | 3 | Jun 28, 2018 |
Rezolute
Jun 2, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $4.00
Upside: +50.00%
MannKind
Jun 1, 2026
Maintained: Buy
Price Target: $8
Current: $3.43
Upside: +133.24%
Kalaris Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $17
Current: $4.65
Upside: +265.59%
Wave Life Sciences
May 27, 2026
Maintained: Buy
Price Target: $15
Current: $5.69
Upside: +163.62%
BioMarin Pharmaceutical
May 21, 2026
Rated: Buy
Price Target: $94
Current: $53.32
Upside: +76.29%
Keros Therapeutics
May 19, 2026
Maintained: Hold
Price Target: $16
Current: $10.55
Upside: +51.66%
Voyager Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $8
Current: $3.59
Upside: +122.84%
Sarepta Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $35
Current: $16.25
Upside: +115.38%
Sagimet Biosciences
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $6.79
Upside: +312.37%
Opus Genetics
May 12, 2026
Maintained: Buy
Price Target: $10
Current: $3.99
Upside: +150.63%
May 11, 2026
Maintained: Buy
Price Target: $34
Current: $17.87
Upside: +90.26%
May 8, 2026
Reiterated: Buy
Price Target: $16
Current: $2.89
Upside: +453.63%
May 8, 2026
Maintained: Buy
Price Target: $8
Current: $3.97
Upside: +101.51%
May 7, 2026
Maintained: Buy
Price Target: $273
Current: $216.60
Upside: +26.04%
May 6, 2026
Rated: Buy
Price Target: $112 → $118
Current: $93.23
Upside: +26.57%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $5.90
Upside: +35.71%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $2.79
Upside: n/a
Mar 30, 2023
Maintained: Hold
Price Target: n/a
Current: $5.69
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $26.76
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $27.43
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $8
Current: $6.41
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $4
Current: $0.3394
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $7.13
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $81.57
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.42
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $19.35
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $14.86
Upside: n/a